A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.

Source:http://linkedlifedata.com/resource/pubmed/id/12045127

Am. J. Respir. Crit. Care Med. 2002 Jun 1 165 11 1526-30

Download in:

View as

Triples

General Info

PMID
12045127